NEW YORK, April 4 (GenomeWeb News) - Incogen said last week that after meeting first-year milestones, it has received the $1.2 million remaining on a $2-million National Institutes of Health grant.
According to Incogen, the grant will help support its research into cancer diagnostics, and involves a collaboration with researchers from the
The NIH award is a Phase II follow-on to a previous grant received in 2003, Incogen said. That first grant provided funding for the development of a pilot project in the analysis of data obtained from surface-enhanced laser desorption ionization mass spectrometry.
The Phase II work is focused on developing a clinical diagnostic software package based on Incogen's Visual Integrated Bioinformatics Environment software.